Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Dissection of the Renal Cell Carcinoma Tumor Microenvironment for the Discovery of Novel Therapeutic Targets

NCT04005183 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04005183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Dissection of the Renal Cell Carcinoma Tumor Microenvironment for the Discovery of Novel Therapeutic Targets
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
May 6, 2019
Completion date
July 20, 2023
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma